SE415980B - Forfarande for framstellning av 7-sybstituerade-3-(3-hydroxipyridazin-6-yltiometyl)-3-cefem-4-karboxylsyror - Google Patents

Forfarande for framstellning av 7-sybstituerade-3-(3-hydroxipyridazin-6-yltiometyl)-3-cefem-4-karboxylsyror

Info

Publication number
SE415980B
SE415980B SE7311703A SE7311703A SE415980B SE 415980 B SE415980 B SE 415980B SE 7311703 A SE7311703 A SE 7311703A SE 7311703 A SE7311703 A SE 7311703A SE 415980 B SE415980 B SE 415980B
Authority
SE
Sweden
Prior art keywords
yltiomethyl
sybstuitude
hydroxipyridazin
cefem
preparing
Prior art date
Application number
SE7311703A
Other languages
English (en)
Swedish (sv)
Inventor
T Naito
J Okumura
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US00285764A external-priority patent/US3813376A/en
Priority claimed from US00286792A external-priority patent/US3823141A/en
Priority claimed from US00286630A external-priority patent/US3813390A/en
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE415980B publication Critical patent/SE415980B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36Methylene radicals, substituted by sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/56Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C247/00Compounds containing azido groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/657Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings
    • C07C49/665Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings a keto group being part of a condensed ring system
    • C07C49/67Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings a keto group being part of a condensed ring system having two rings, e.g. tetralones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7311703A 1972-08-31 1973-08-28 Forfarande for framstellning av 7-sybstituerade-3-(3-hydroxipyridazin-6-yltiometyl)-3-cefem-4-karboxylsyror SE415980B (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US00285764A US3813376A (en) 1972-08-31 1972-08-31 7-(o-aminomethylphenyl-acetamido)-3-(3-hydroxypyridazin-6-ylthiomethyl)-3-cephem-4-carboxylic acid
US00286792A US3823141A (en) 1972-09-06 1972-09-06 7-(o-aminomethyl-p-hydroxy-phenylacetamido)-3-(3-hydroxy-pyridazin-6-ylthiomethyl)-3-cephem-4-carboxylic acid
US00286630A US3813390A (en) 1972-09-06 1972-09-06 7-(o-aminomethylphenylthioacetamido)-3-(3-hydroxypyridazin-6-ylthiomethyl)-3-cephem-4-carboxylic acid

Publications (1)

Publication Number Publication Date
SE415980B true SE415980B (sv) 1980-11-17

Family

ID=27403558

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7311703A SE415980B (sv) 1972-08-31 1973-08-28 Forfarande for framstellning av 7-sybstituerade-3-(3-hydroxipyridazin-6-yltiometyl)-3-cefem-4-karboxylsyror

Country Status (10)

Country Link
JP (1) JPS5930716B2 (enrdf_load_html_response)
AU (1) AU476592B2 (enrdf_load_html_response)
DE (1) DE2344095A1 (enrdf_load_html_response)
DK (1) DK145465C (enrdf_load_html_response)
ES (1) ES418328A1 (enrdf_load_html_response)
FI (1) FI57420C (enrdf_load_html_response)
FR (1) FR2279408A1 (enrdf_load_html_response)
GB (1) GB1412721A (enrdf_load_html_response)
NL (1) NL7312062A (enrdf_load_html_response)
SE (1) SE415980B (enrdf_load_html_response)

Also Published As

Publication number Publication date
DK145465C (da) 1983-04-18
FR2279408B1 (enrdf_load_html_response) 1978-07-28
FI57420C (fi) 1980-08-11
DK145465B (da) 1982-11-22
NL7312062A (enrdf_load_html_response) 1974-03-04
JPS5930716B2 (ja) 1984-07-28
GB1412721A (en) 1975-11-05
ES418328A1 (es) 1976-09-01
AU476592B2 (en) 1976-09-30
FR2279408A1 (fr) 1976-02-20
AU5974273A (en) 1975-03-06
FI57420B (fi) 1980-04-30
DE2344095A1 (de) 1974-04-18
JPS4992091A (enrdf_load_html_response) 1974-09-03

Similar Documents

Publication Publication Date Title
SE404019B (sv) Forfarande for framstellnig av n-fosfonometylglycin
SE395366B (sv) Forfarande for framstellning av porosa tabletter
SE400771B (sv) Forfarande for framstellning av 3alfa-hydroxi- och 3alfa-hydroxi-19-norpregnaner
SE7308234L (sv) Forfarande for framstellning av o-substituerade 7beta-amino-3-cefem-3-ol-4-karboxylsyraforeningar
SE413246B (sv) Forfarande for framstellning av kolesteroloxidas
SE419339B (sv) Forfarande for framstellning av substituerade sulfonylacetamidocefalosporiner
SE428218B (sv) Forfarande for framstellning av 6-aminopenicillansyra
NO137589C (no) Fremgangsmaate for fremstilling av fosforsyre
SE397530B (sv) Forfarande for framstellning av 1-pyrazolylalkyl-4-arylpiperazinderivat
NO139124C (no) Fremgangsmaate for fremstilling av estere
SE414164B (sv) Forfarande for framstellning av fosforsyra
SE416473B (sv) Forfarande for framstellning av 7-(alfa-hydroxi-alfa-fenyl) acetamido-3-(1-metyl-1h-tetrazol-5-yltiometyl)-3-cefem-4-karbonsyra
SE423092B (sv) Forfarande for framstellning av vissa 13-tiaprostaglandiner
SE7611202L (sv) Forfarande for framstellning av pyrazolodiazepinforeningar
SE382809B (sv) Forfarande for framstellning av fenoxiettiksyraderivat
SE416725B (sv) Forfarande for framstellning av p-nitrobensoesyra
FI55626C (fi) Anordning foer framstaellning av en behaollare
SE428692B (sv) Forfarande for framstellning av 7beta-amino-3-cefem-4-karboxylsyraforeningar
NO139130C (no) Fremgangsmaate til fremstilling av 2-alkylamino-dihydropyridiner
SE387344B (sv) Forfarande for framstellning av pyrazin-4-oxidderivat
NO147644C (no) Fremgangsmaate for fremstilling av 6-amino-penicillansyre
SE385581B (sv) Forfarande for framstellning av foretrade n-metylolkarbamidforeningar
IT999554B (it) Procedimento per preparare diacetossibutano
IT1033071B (it) Procedimento per prepare tiazolsolfenammidi
SE402454B (sv) Forfarande for framstellning av 2-alkoxi-5-alkylsulfonyl-toluen